Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
19,218 Lung Cancer
clinical trials

Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Honolulu, HI
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Joplin, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Lawrence, KS
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Lowell, MA
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Mankato, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Maryville, TN
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Muncie, IN
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Newark, DE
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Newark, DE
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Oakland, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Parma, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Roseville, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Sacramento, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Santa Clara, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Savannah, GA
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Savannah, GA
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Staten Island, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Summit, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Syracuse, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Twin Falls, ID
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Vallejo, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
West Reading, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Wisconsin Rapids, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Worcester, MA
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
Study of OSE2101 Versus Standard Treatment as 2nd or 3rd Line in HLA-A2 Positive Patients With Advanced NSCLC After Failure of Immune Checkpoint Inhibitor
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Dallas, TX
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
Study of OSE2101 Versus Standard Treatment as 2nd or 3rd Line in HLA-A2 Positive Patients With Advanced NSCLC After Failure of Immune Checkpoint Inhibitor
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Hot Springs, AR
Click here to add this to my saved trials
Advanced Cancer Clinical Trial
An Investigational Immuno-therapy Study to Test Combination Treatments in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Advanced Cancer Clinical Trial
An Investigational Immuno-therapy Study to Test Combination Treatments in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Boston, MA
Click here to add this to my saved trials
Advanced Cancer Clinical Trial
An Investigational Immuno-therapy Study to Test Combination Treatments in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Houston, TX
Click here to add this to my saved trials
Advanced Cancer Clinical Trial
An Investigational Immuno-therapy Study to Test Combination Treatments in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
La Jolla, CA
Click here to add this to my saved trials
Advanced Cancer Clinical Trial
An Investigational Immuno-therapy Study to Test Combination Treatments in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Advanced Cancer Clinical Trial
An Investigational Immuno-therapy Study to Test Combination Treatments in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Nashville, TN
Click here to add this to my saved trials
Advanced Cancer Clinical Trial
An Investigational Immuno-therapy Study to Test Combination Treatments in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Mesothelioma Clinical Trial
MEDI4736 Or MEDI4736 + Tremelimumab In Surgically Resectable Malignant Pleural Mesothelioma
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab Plus Bevacizumab for Treatment of Brain Metastases in Metastatic Melanoma or Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Tampa, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Study to Assess the Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Brain Metastases From Non-small Cell Lung Cancer (NSCLC) Clinical Trial
Effect of TTFields (150 kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-10 Brain Metastases Following Radiosurgery (METIS)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Austin, TX
Click here to add this to my saved trials
Brain Metastases From Non-small Cell Lung Cancer (NSCLC) Clinical Trial
Effect of TTFields (150 kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-10 Brain Metastases Following Radiosurgery (METIS)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Greenville, NC
Click here to add this to my saved trials
Brain Metastases From Non-small Cell Lung Cancer (NSCLC) Clinical Trial
Effect of TTFields (150 kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-10 Brain Metastases Following Radiosurgery (METIS)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Brain Metastases From Non-small Cell Lung Cancer (NSCLC) Clinical Trial
Effect of TTFields (150 kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-10 Brain Metastases Following Radiosurgery (METIS)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Lubbock, TX
Click here to add this to my saved trials
Brain Metastases From Non-small Cell Lung Cancer (NSCLC) Clinical Trial
Effect of TTFields (150 kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-10 Brain Metastases Following Radiosurgery (METIS)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
New Orleans, LA
Click here to add this to my saved trials
Brain Metastases From Non-small Cell Lung Cancer (NSCLC) Clinical Trial
Effect of TTFields (150 kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-10 Brain Metastases Following Radiosurgery (METIS)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Brain Metastases From Non-small Cell Lung Cancer (NSCLC) Clinical Trial
Effect of TTFields (150 kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-10 Brain Metastases Following Radiosurgery (METIS)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Plantation, FL
Click here to add this to my saved trials
Brain Metastases From Non-small Cell Lung Cancer (NSCLC) Clinical Trial
Effect of TTFields (150 kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-10 Brain Metastases Following Radiosurgery (METIS)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Sacramento, CA
Click here to add this to my saved trials
Brain Metastases From Non-small Cell Lung Cancer (NSCLC) Clinical Trial
Effect of TTFields (150 kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-10 Brain Metastases Following Radiosurgery (METIS)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
San Francisco, CA
Click here to add this to my saved trials
Carcinoma, Non-Small-Cell Lung Clinical Trial
A Trial of TAK-788 (AP32788) in Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Boston, MA
Click here to add this to my saved trials
Carcinoma, Non-Small-Cell Lung Clinical Trial
A Trial of TAK-788 (AP32788) in Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Atlanta, GA
Click here to add this to my saved trials
Carcinoma, Non-Small-Cell Lung Clinical Trial
A Trial of TAK-788 (AP32788) in Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Fairfax, VA
Click here to add this to my saved trials
Carcinoma, Non-Small-Cell Lung Clinical Trial
A Trial of TAK-788 (AP32788) in Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Orlando, FL
Click here to add this to my saved trials
Carcinoma, Non-Small-Cell Lung Clinical Trial
A Trial of TAK-788 (AP32788) in Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Whittier, CA
Click here to add this to my saved trials
Oncology Clinical Trial
MAGE A10ᶜ⁷⁹⁶T for Advanced NSCLC
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Oncology Clinical Trial
A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Port Saint Lucie, FL
Click here to add this to my saved trials
Oncology Clinical Trial
A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
San Diego, CA
Click here to add this to my saved trials
Oncology Clinical Trial
A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Port Saint Lucie, FL
Click here to add this to my saved trials
Oncology Clinical Trial
LCL161 Plus Topotecan for Patients With Relapsed/Refractory Small Cell Lung Cancer and Select Gynecologic Malignancies
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Nashville, TN
Click here to add this to my saved trials
Oncology Clinical Trial
Sym015 (Anti-MET) in Patients With Advanced Solid Tumor Malignancies
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Dallas, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Genetic Predictors of Benefit to Pembrolizumab
Status: Enrolling, Phase II
Updated: 11/3/2017
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Genetic Predictors of Benefit to Pembrolizumab
Status: Enrolling, Phase II
Updated: 11/3/2017
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Genetic Predictors of Benefit to Pembrolizumab
Status: Enrolling, Phase II
Updated: 11/3/2017
mi
from
New York, NY
Click here to add this to my saved trials
Carcinoma, Non-Small-Cell Lung Clinical Trial
Neoadjuvant MPDL3280A, Nab-paclitaxel and Carboplatin (MAC) in NSCLC
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Tampa, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Weston, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Atlanta, GA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Clearwater, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Iowa City, IA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Mobile, AL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
New Orleans, LA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Richmond, VA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Rochester, MN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Tucson, AZ
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
Status: Enrolling
Updated: 12/31/1969
mi
from
Augusta, GA
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
Status: Enrolling
Updated: 12/31/1969
mi
from
Bloomington, IL
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
Status: Enrolling
Updated: 12/31/1969
mi
from
Boise, ID
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
Status: Enrolling
Updated: 12/31/1969
mi
from
Bozeman, MT
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
Status: Enrolling
Updated: 12/31/1969
mi
from
Carthage, IL
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
Status: Enrolling
Updated: 12/31/1969
mi
from
Chanute, KS
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
Status: Enrolling
Updated: 12/31/1969
mi
from
Chippewa Falls, WI
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
Status: Enrolling
Updated: 12/31/1969
mi
from
Detroit, MI
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
Status: Enrolling
Updated: 12/31/1969
mi
from
Grand Island, NE
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
Status: Enrolling
Updated: 12/31/1969
mi
from
Greenville, SC
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
Status: Enrolling
Updated: 12/31/1969
mi
from
Kingman, KS
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
Status: Enrolling
Updated: 12/31/1969
mi
from
Memphis, TN
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
Status: Enrolling
Updated: 12/31/1969
mi
from
Meridian, ID
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
Status: Enrolling
Updated: 12/31/1969
mi
from
Mount Airy, NC
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
Status: Enrolling
Updated: 12/31/1969
mi
from
Nashville, TN
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
Status: Enrolling
Updated: 12/31/1969
mi
from
Pekin, IL
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
Status: Enrolling
Updated: 12/31/1969
mi
from
Sidney, OH
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
Status: Enrolling
Updated: 12/31/1969
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
Status: Enrolling
Updated: 12/31/1969
mi
from
Springfield, MO
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
Status: Enrolling
Updated: 12/31/1969
mi
from
Tacoma, WA
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
Status: Enrolling
Updated: 12/31/1969
mi
from
Wellington, KS
Click here to add this to my saved trials
1 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 192